Inactive Instrument

PLx Pharma Winddown Corp. Stock price

Equities

PLXP

US72942A1079

Dynamic Chart
Managers TitleAgeSince
Corporate Officer/Principal - 23-03-06
Corporate Officer/Principal 47 23-03-06
Sales & Marketing - 17-10-01
Members of the board TitleAgeSince
Director/Board Member 80 16-01-31
Chairman 70 11-06-30
Director/Board Member 65 16-01-31
More insiders
PLx Pharma Winddown Corp., formerly PLx Pharma Inc., is a commercial-stage drug delivery platform technology company. The Company is focused on improving how and where active pharmaceutical ingredients (APIs) are absorbed in the gastrointestinal (GI) tract via its clinically validated and patent-protected PLxGuard technology. The Company has two Food and Drug Administration (FDA) approved products, VAZALORE 81 mg and VAZALORE 325 mg (VAZALORE), which are liquid-filled aspirin capsules for over-the-counter distribution (OTC). The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation. It also screens additional compounds outside the NSAID category for possible development using its PLxGuard drug delivery platform.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock PLx Pharma Winddown Corp. - OTC Markets